These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 2983127)

  • 21. Impairment of cellular immunity and OKT4 lymphocytes in symptom-free hemophiliacs with antibodies to human T leukemia virus III (HTLV III).
    Pandolfi F; De Rossi G; Mariani G; Carbonari M; Ensoli B; Napolitano M; Lopez M; Mandelli F; Aiuti F
    Diagn Immunol; 1985; 3(3):155-9. PubMed ID: 2996821
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intra-blood-brain-barrier synthesis of HTLV-III-specific IgG in patients with neurologic symptoms associated with AIDS or AIDS-related complex.
    Resnick L; diMarzo-Veronese F; Schüpbach J; Tourtellotte WW; Ho DD; Müller F; Shapshak P; Vogt M; Groopman JE; Markham PD
    N Engl J Med; 1985 Dec; 313(24):1498-504. PubMed ID: 2999592
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unique pattern of HTLV-III (AIDS-related) antigen recognition by sera from African children in Uganda (1972).
    Saxinger C; Levine PH; Dean A; Lange-Wantzin G; Gallo R
    Cancer Res; 1985 Sep; 45(9 Suppl):4624s-4626s. PubMed ID: 2990697
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Seroepidemiological studies of HTLV-III antibody prevalence among selected groups of heterosexual Africans.
    Clumeck N; Robert-Guroff M; Van de Perre P; Jennings A; Sibomana J; Demol P; Cran S; Gallo RC
    JAMA; 1985 Nov; 254(18):2599-602. PubMed ID: 2997491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HTLV and immunosuppression.
    Essex M; Kanki P; Allan J; Barin F; McLane MF; Lee TH; Kitchen L; Homma T; Malone G; Yokota T
    Princess Takamatsu Symp; 1984; 15():309-18. PubMed ID: 6100649
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human T-lymphotropic virus type III infection in previously immunocompromised hosts.
    Groopman JE; Hammer SM; Sallan SE; Allan JD
    J Clin Oncol; 1986 Apr; 4(4):540-3. PubMed ID: 3007685
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Seroepidemiological studies of human T-lymphotropic retrovirus type III in acquired immunodeficiency syndrome.
    Safai B; Sarngadharan MG; Groopman JE; Arnett K; Popovic M; Sliski A; Schüpbach J; Gallo RC
    Lancet; 1984 Jun; 1(8392):1438-40. PubMed ID: 6145881
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HTLV-III AIDS link.
    Bennett JA
    Am J Nurs; 1985 Oct; 85(10):1086-9. PubMed ID: 2996353
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of transmission of HTLV-III/LAV infection to household contacts of patients with AIDS or AIDS-related complex with oral candidiasis.
    Friedland GH; Saltzman BR; Rogers MF; Kahl PA; Lesser ML; Mayers MM; Klein RS
    N Engl J Med; 1986 Feb; 314(6):344-9. PubMed ID: 3456076
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HTLV-III infection among health care workers. Association with needle-stick injuries.
    Weiss SH; Saxinger WC; Rechtman D; Grieco MH; Nadler J; Holman S; Ginzburg HM; Groopman JE; Goedert JJ; Markham PD
    JAMA; 1985 Oct; 254(15):2089-93. PubMed ID: 2995694
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunological properties of HTLV-III antigens recognized by sera of patients with AIDS and AIDS-related complex and of asymptomatic carriers of HTLV-III infection.
    Sarngadharan MG; diMarzo Veronese F; Lee S; Gallo RC
    Cancer Res; 1985 Sep; 45(9 Suppl):4574s-4577s. PubMed ID: 2410106
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A prospective study of male sexual contacts of men with AIDS-related conditions (ARC) or AIDS: HTLV-III antibody, clinical, and immune function status at induction.
    Coates RA; Soskolne CL; Read SE; Fanning MM; Klein MM; Shepherd FA; Calzavara L; Johnson JK; O'Shaughnessey MV
    Can J Public Health; 1986; 77 Suppl 1():26-32. PubMed ID: 3017532
    [No Abstract]   [Full Text] [Related]  

  • 33. Evidence for exposure to HTLV-III in Uganda before 1973.
    Saxinger WC; Levine PH; Dean AG; de Thé G; Lange-Wantzin G; Moghissi J; Laurent F; Hoh M; Sarngadharan MG; Gallo RC
    Science; 1985 Mar; 227(4690):1036-8. PubMed ID: 2983417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders. Contribution of antibody-producing B cells, of Epstein-Barr virus-infected B cells, and of immunoglobulin production induced by human T cell lymphotropic virus, type III/lymphadenopathy-associated virus.
    Yarchoan R; Redfield RR; Broder S
    J Clin Invest; 1986 Aug; 78(2):439-47. PubMed ID: 3016028
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serological characterization of HTLV-III infection in AIDS and related disorders.
    Groopman JE; Chen FW; Hope JA; Andrews JM; Swift RL; Benton CV; Sullivan JL; Volberding PA; Sites DP; Landesman S
    J Infect Dis; 1986 Apr; 153(4):736-42. PubMed ID: 3005434
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low prevalence in the UK of HTLV-I and HTLV-II infection in subjects with AIDS, with extended lymphadenopathy, and at risk of AIDS.
    Tedder RS; Shanson DC; Jeffries DJ; Cheingsong-Popov R; Clapham P; Dalgleish A; Nagy K; Weiss RA
    Lancet; 1984 Jul; 2(8395):125-8. PubMed ID: 6146034
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Infection with HTLV-III/LAV and transfusion-associated acquired immunodeficiency syndrome. Serologic evidence of an association.
    Jaffe HW; Sarngadharan MG; DeVico AL; Bruch L; Getchell JP; Kalyanaraman VS; Haverkos HW; Stoneburner RL; Gallo RC; Curran JW
    JAMA; 1985 Aug; 254(6):770-3. PubMed ID: 2989568
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human T-cell leukemia virus: its discovery and role in leukemogenesis and immunosuppression.
    Shaw GM; Broder S; Essex M; Gallo RC
    Adv Intern Med; 1984; 30():1-27. PubMed ID: 6084947
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Additional recommendations to reduce sexual and drug abuse-related transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1986 Mar; 35(10):152-5. PubMed ID: 3005822
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HTLV-III in saliva of people with AIDS-related complex and healthy homosexual men at risk for AIDS.
    Groopman JE; Salahuddin SZ; Sarngadharan MG; Markham PD; Gonda M; Sliski A; Gallo RC
    Science; 1984 Oct; 226(4673):447-9. PubMed ID: 6093247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.